<DOC>
	<DOCNO>NCT02623868</DOCNO>
	<brief_summary>Study assess pharmacokinetic/pharmacodynamic characteristic safety/tolerability CKD-519 new formulation healthy male subject .</brief_summary>
	<brief_title>Study Assess PK/PD Character , Safety/Tolerability CKD-519 New Formulation Healthy Male Subject .</brief_title>
	<detailed_description>Open-label , Randomized , 3-period , 6-sequence , crossover study</detailed_description>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>1 . Between 20 age 45 age healthy male adult 2 . Body weight ≥ 50kg range calculate BMI ( Body Mass Index ) 18~29kg/m2 3 . Subject sign inform consent form willingly 4 . Necessarily agree use double contraception sperm donation two month clinical trial final dosage investigational product 1 . Clinically significant disease cardiovascular , respiratory , hepatobiliary , nephrological , hematological , gastrointestinal , endocrine , immune , integumentary , neurologic , psychiatric system 2 . Have acute disease within 28 day begin study treatment 3 . Have disease history effect drug absorption , distribution , metabolism , excretion 4 . Have clinically significant chronic disease 5 . Systolic blood pressure 〈100mmHg 〉140mmHg , diastolic blood pressure〈60mmHg 〉90mmHg 6 . Positive serology test ( HBsAg , antiHCV Ab , antiHIV Ab , VDRL ( Venereal Disease Research Laboratories ) ) 7 . Subject treated ethical drug within 14 day begin study treatment 8 . Subject treat overthecounter herbal medicine within 7 day begin study treatment 9 . Have clinically significant allergic disease ( except mild allergic rhinitis , allergic dermatitis drug ) 10 . Can take standard Meal 11 . Whole blood donation within 60 day prior first dose component blood donation within 20 day prior first dose 12 . Blood transfusion within 30 day 13 . Taking drug receive investigational drug within 90 day prior first dose 14 . Continuously take caffeine ( 〉5 cups/day ) , drink alcohol ( 〉30g/day ) , smoke excessive cigarette ( 〉10cigarettes/day ) 15 . Impossible participant clinical trial investigator 's decision include laboratory test result another reasone ( example , noncompliance , disoblige manner ) 16 . Subject treat metabolize enzyme inducer inhibitor include barbiturate within 30 day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>